Communication of individuals with CDKL5 deficiency disorder as observed by caregivers: A descriptive qualitative study.

Autor: Keeley, Jessica, Benson‐Goldberg, Sofia, Saldaris, Jacinta, Lariviere, Judy, Leonard, Helen, Marsh, Eric D., Demarest, Scott T., Benke, Tim A., Jacoby, Peter, Downs, Jenny
Zdroj: American Journal of Medical Genetics. Part A; Jul2024, Vol. 194 Issue 7, p1-14, 14p
Abstrakt: CDKL5 deficiency disorder (CDD) is a genetically caused developmental epileptic encephalopathy that causes severe communication impairments. Communication of individuals with CDD is not well understood in the literature and currently available measures are not well validated in this population. Accurate and sensitive measurement of the communication of individuals with CDD is important for understanding this condition, clinical practice, and upcoming interventional trials. The aim of this descriptive qualitative study was to understand how individuals with CDD communicate, as observed by caregivers. Participants were identified through the International CDKL5 Disorder Database and invited to take part if their child had a pathogenic variant of the CDKL5 gene and they had previously completed the Communication and Symbolic Behavior Checklist (CSBS‐DP ITC). The sample comprised caregivers of 23 individuals with CDD, whose ages ranged from 2 to 30 years (median 13 years), 15 were female, and most did not use words. Semistructured interviews were conducted via videoconference and analyzed using a conventional content analysis. Three overarching categories were identified: mode, purpose and meaning, and reciprocal exchanges. These categories described the purposes and mechanism of how some individuals with CDD communicate, including underpinning influential factors. Novel categories included expressing a range of emotions, and reciprocal exchanges (two‐way interactions that varied in complexity). Caregivers observed many communication modes for multiple purposes. Understanding how individuals with CDD communicate improves understanding of the condition and will guide research to develop accurate measurement for clinical practice and upcoming medication trials. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index